Zentiva Acquires Five Herbal Brands from Aboca to Expand Consumer Healthcare

Zentiva, a prominent player in the European pharmaceutical industry, has announced the impending acquisition of five established brands from Aboca, an Italian company known for its plant-based healthcare products. The acquisition, which will be finalized on June 30, 2025, marks a strategic expansion of Zentiva’s Consumer Healthcare portfolio, enhancing its capabilities in offering natural remedies across Europe. The brands joining Zentiva’s lineup include Propol2 EMF, Ruscoven, Serenil, Fisiodepur, and Finocarbo, targeting key self-care categories such as respiratory, circulatory, and relaxation solutions. This move aligns with Zentiva’s ambition to capitalize on the growing consumer preference for natural and sustainable healthcare options. Zentiva’s CEO Steffen Saltofte emphasized the significance of integrating Aboca’s herbal expertise with Zentiva’s extensive healthcare network to strengthen its leadership in the Consumer Healthcare sector. By extending its reach into markets like Italy, Spain, and France, and planning for further geographical expansion, Zentiva looks to leverage these brands to solidify its position as a leading provider of accessible health and wellness solutions.